(原标题:【券商聚焦】国元证券:关注创新药及AI赛道投资机会)金吾财讯|国元证券发布研报指,港股市场结构性机会显现,重点推荐创新药及AI科技板块。报告覆盖和誉-B(02256.HK)、基石药业-B(02616.HK)等创新药企,指出和誉-B肿瘤管线临床进展领先,与Merck合作协议总金额达6.055亿美元;基石药业-B三特异性抗体CS2009具备全球竞争力。AI领域推荐阿里巴巴-W(09988....
Source Link(原标题:【券商聚焦】国元证券:关注创新药及AI赛道投资机会)金吾财讯|国元证券发布研报指,港股市场结构性机会显现,重点推荐创新药及AI科技板块。报告覆盖和誉-B(02256.HK)、基石药业-B(02616.HK)等创新药企,指出和誉-B肿瘤管线临床进展领先,与Merck合作协议总金额达6.055亿美元;基石药业-B三特异性抗体CS2009具备全球竞争力。AI领域推荐阿里巴巴-W(09988....
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.